Pargluva, a proposed diabetes drug from Bristol-Myers Squibb and Merck & Company, appears to increase the risk of death, heart attack or stroke, according to a study published in a leading medical journal last week.
The study was conducted by the two Cleveland Clinic cardiologists who warned in 2001 about the cardiovascular risks associated with Vioxx, […]